380 results on '"Cunningham, D."'
Search Results
2. PO-1167 Low dose radiotherapy in indolent lymphoma involving the orbit- a 21-year single centre experience
3. The Use of Tumour Marker Ca19.9 in the Follow up of Patients with Resected Biliary Tract Cancer: Results from the BILCAP Randomised Clinical Trial
4. Robotic Celiac Artery Resection with Distal Pancreatic Splenectomy Following Common Hepatic Artery Ligation. A Novel Approach to Pancreatic Cancer Encasing Celiac Axis
5. CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial
6. 87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience
7. Descriptive Statistics for Patients with Glioblastoma Associated with Germline Mismatch Repair Gene Mutation
8. Modern Outcomes of Pediatric and Young Adult Patients with Parotid Gland Tumors Treated with Highly-Conformal Radiation Therapy
9. Extranodal risk sites for CNS lymphoma: Review, good practice guide and the new SIHMIR paradigm shift
10. 1253P Safety and efficacy of Wnt inhibition with a DKK1 inhibitor, DKN-01, in combination with atezolizumab in patients with advanced oesophagogastric adenocarcinoma: Phase IIa results of the WAKING trial
11. CN45 The Gastrointestinal and Lymphoma Unit Advanced Nurse Practitioner role in clinical research at The Royal Marsden Hospital
12. 1209P A phase II study of regorafenib in combination with nivolumab in patients with recurrent or metastatic solid tumors: Results of the ESCC cohort
13. 1226P Predicting benefit from maintenance durvalumab after first-line chemotherapy (1L CTx) in oesophagogastric adenocarcinoma (OGA) using a novel tumour microenvironment (TME) RNA-based assay
14. 633P Determining the prognostic value of end of treatment (EOT) 18F-choline positron emission tomography (PET) in patients treated with primary central nervous system lymphoma (PCNSL) who respond to first-line therapy: A single centre retrospective study at the Royal Marsden Hospital (RMH)
15. PD-2 EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma
16. SO-9 Pathological primary tumour and lymph node regression following neoadjuvant chemotherapy in resectable oesophagogastric cancer: Pooled analysis of 1619 patients from two randomised trials
17. SO-4 Individual participant data network meta-analysis (IPD-NMA) of neoadjuvant chemotherapy or chemoradiotherapy in esophageal or gastro-esophageal junction carcinoma
18. SO-5 Disease-free survival as surrogate for overall survival in neoadjuvant chemo(radio)therapy treatment of esophageal or gastro-esophageal junction carcinoma: An analysis of 4518 individual patients and 22 trials
19. Radiology of Castleman disease: the pivotal role of imaging in diagnosis, staging, and response assessment of this rare entity
20. SO-10 The prognostic role of microarchitecture in tumour-positive lymph nodes in oesophageal cancer patients: Results from the UK MRC OE02 trial
21. The Influence of Procedural Volume on Short-Term Outcomes for Robotic Pancreaticoduodenectomy
22. Can We Predict the Progression of Premalignant Pancreatic Cystic Tumours to Ductal Adenocarcinoma? A Literature Reviewa New Parenchyma-Sparing Procedures for Deep-Located Hepatic Tumors
23. POSB405 Data Governance for Rwd/E Management: Optimising Its Use in HTA and Decision-Making
24. Pediatric Patient-Reported Quality of Life Before and after Radiotherapy: A Prospective Registry Study
25. Lymphopenia in Pediatric Patients Following Proton Radiotherapy
26. A Comparison of Oncologic Outcomes and Toxicity with Combined Modality Therapy vs. Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer in Previously Irradiated Patients
27. 297: Promising pilot study data of dyadic telehealth acceptance and commitment therapy for anxiety and depression in teens with CF and their caregivers and siblings
28. Chronic lymphocytic leukaemia and Richter's transformation: multimodal review and new imaging paradigms
29. 443P EMERGE: A phase II trial assessing the efficacy of domatinostat plus avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal cancers – phase IIA dose finding
30. 447P The prognostic factors in early stage BRAF mutant colorectal cancer: Experience from a large volume UK tertiary centre
31. 453P Routine DPYD mutation testing for patients receiving fluoropyrimidines for gastrointestinal (GI) cancers: Real world experience in a tertiary UK oncology centre
32. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): a good practice guide, pictorial review, and new perspectives
33. O-15 Randomized, phase 3 study of second-line tislelizumab vs chemotherapy in advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302) in the overall population and Europe/North America subgroup
34. SO-6 Microarchitectural changes in regional lymph nodes after chemotherapy in oesophageal cancer: Results from the UK MRC OE02 trial
35. Explosive Outbursts at School
36. Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift
37. O-15 Randomized, phase 3 study of second-line tislelizumab vs chemotherapy in advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302) in the overall population and Europe/North America subgroup
38. PMU112 Context Matters — a Taxonomy of Real-World DATA and Evidence to Support HTA Decision-Making
39. Proton Whole Lung Radiation Therapy: Initial Report of Outcomes
40. ESPAC-4: A randomized controlled phase III trial of adjuvant gemcitabine (GEM) and capecitabine (CAP) versus gemcitabine in resected pancreatic ductal adenocarcinoma: five year follow up.
41. P-138 A comparison of the transcriptomic profiles of matched tissue from primary colorectal cancer and corresponding secondary lung metastases
42. Deep learning as a staging tool in gastric cancer
43. O-9 Discordant prognostic significance of negative lymph node size in patients with oesophageal cancer treated with either surgery or neoadjuvant chemotherapy and surgery: Results from the MRC OE02 trial
44. Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
45. Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group
46. A personalised approach for anti-GITR-based immunotherapy in pre-clinical models of pancreatic ductal adenocarcinoma
47. Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of response to DNA damage
48. Circulating miR-652-3p as a biomarker of drug resistance in metastatic colorectal cancer patients
49. Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
50. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.